Background--The redox-sensitive chaperone DJ-1 and uncoupling protein 2 are protective against mitochondrial oxidative stress. We previously reported that renal-selective depletion and germline deletion of DJ-1 increases blood pressure in mice. This study aimed to determine the mechanisms involved in the oxidative stress-mediated hypertension in DJ-1 À/À mice.
C ardiovascular diseases are the leading cause of mortality and morbidity worldwide, especially in patients with chronic kidney disease. 1 Hypertension, the most prevalent cardiovascular risk factor, is known to be associated with oxidative stress. 2 However, hypertension can be both a cause and a consequence of oxidative stress (eg, reactive oxygen species [ROS] and reactive nitrogen species). 2 DJ-1, also known as PARK-7, is a multifunctional oxidative stress response protein that functions as a redox-sensitive chaperone with intrinsic antioxidant properties, especially in the mitochondria, and regulates the expression of several antioxidant genes such as Hsp70 and glutathione. 3, 4 Although originally associated with Parkinson's disease, DJ-1 is expressed not only in brain, but also in heart, kidney, liver, pancreas, and skeletal muscle in rodents and humans. 5 DJ-1 is present mainly in the cytoplasm and, to a lesser extent, in the mitochondria. However, following an oxidative challenge, there is increased translocation of DJ-1 into the mitochondria, resulting in the protection of mitochondrial function. 6 Our group reported that the anti-oxidant and antiinflammatory properties of the dopamine 2 receptor (D 2 R) are mediated in part by DJ-1. [7] [8] [9] Renal-selective silencing of DJ-1 in mice, via the renal subcapsular infusion of DJ-1 siRNA, impairs the D 2 R-mediated antioxidant response. 9, 10 In addition, mice with DJ-1 selectively silenced in the kidney and mice with germline deletion of DJ-1 (DJ-1 À/À ) develop high blood pressure (BP), associated with decreased expression and activity of nuclear factor erythroid 2-related factor 2 in the kidney, 10 suggesting that DJ-1 can inhibit renal ROS production, at least in part, via the activation of nuclear factor erythroid 2-related factor 2-regulated antioxidant genes.
Uncoupling proteins (UCPs) facilitate the transfer of anions from the inner to the outer mitochondrial membrane, as well as the return of protons to the electron transport chain. It was recently demonstrated that the main function of UCP2 is the control of mitochondria-derived ROS production. 11 Increased expression of UCP2 by peroxisome-proliferator-activated receptor b/d activation ameliorates the lipopolysaccharidehuman cardiomyocyte-induced endothelial dysfunction in mice, associated with a reduction in intracellular oxidative stress. 12 Upregulation of UCP2 expression also protects from the mitochondrial damage induced by high glucose. 13 UCP2 may be effective in treating diabetic vascular complications by decreasing ROS production by the mitochondria. 14 However, depletion of Ucp2 in mice attenuates the cardiac hypertrophy induced by transverse aortic constriction. 15 Although UCP2 acts to protect the liver against elevated ROS production during drug-induced hepatotoxicity, 16 it also induces chronic depletion of ATP, which can increase the susceptibility of the hepatocytes to ischemia-reperfusion injury in acute energy demand conditions. 17 Therefore, UCP2 has antioxidant properties but, depending upon the concentration, duration of activation, and environmental conditions, UCP2 may also have deleterious effects on physiological functions. 15, 17 The main purpose of this study was to determine the mechanism(s) involved in the development of the high BP associated with depletion of DJ-1.
Materials and Methods
The data that support the findings of this study are available from the corresponding author upon reasonable request.
DJ-1 Deficient (DJ-1 À/À ) Mice
The original F2 hybrid strain (129/SvXC57Bl/6J, Oregon Health Sciences University) containing the mutated DJ-1 allele
) was backcrossed to wild-type C57Bl/6J for >20 generations and genotyped. All mice were obtained from Jackson Laboratory (Bar Harbor, ME) and were bred in the Animal Care Facility of George Washington University. Male DJ-1 À/À mice and wild-type littermates were studied at 6 to 8 weeks of age. All studies were approved by the Animal Care and Use Committee of George Washington University. Mice were housed in metabolic cages the day before BP measurement for collection of 24-hour urine samples.
BP Measurement
For measuring BP, we use the Cardiomax-II system (Columbus Instruments International, Columbus, OH), which is a thermodilution cardiac output computer that has been validated for physiological data acquisition system. It is intended to be used on a variety of laboratory animals such as mice to measure BP. Mice were anesthetized with pentobarbital (50 mg/kg IV) and catheters were inserted into the femoral vessels for fluid administration and BP monitoring. Systolic BP was recorded 1 hour after the induction of anesthesia, when the BP was stable. Mice were euthanized (pentobarbital 100 mg/kg, ip) at the conclusion of the study and organs were harvested and flash-frozen, for analysis.
Acute Renal-Selective Downregulation of Ucp2
Renal cortical Ucp2 was silenced by the renal subcapsular infusion of specific siRNA, via an osmotic minipump. 9, 10 In brief, adult male C57Bl/6J mice were uninephrectomized 1 week before the implantation of osmotic minipumps. For implantation of the minipumps, mice were anesthetized with pentobarbital (50 mg/kg body weight, ip). Osmotic minipumps (ALZET â Osmotic Pump, Cupertino, CA; 100 lL; flow rate 0.5 lL/hour for 7 days) were filled with previously validated DJ-1-specific siRNA (delivery rate, 3 lg/day) or nonsilencing siRNA, as control dissolved in transfection reagent (TransIT â In Vivo Gene Delivery System; Mirus Bio LLC, Madison, WI) under sterile conditions. Each minipump was fitted with polyethylene delivery tubing (Alzet #0007701, Cupertino, CA) and the tip of the tubing was inserted within the subcapsular space of the remaining kidney. Surgical glue was applied at the puncture site to hold the tube in place and prevent extrarenal leakage. The osmotic pump was sutured to the abdominal wall to prevent excessive movement.
9,10
Treatment With Tempol DJ-1 À/À mice and wild-type littermates were treated with tempol (6 mmol/L) in the drinking water or regular water for 2 weeks. 18 Fresh tempol was dissolved in water every day and protected from light. After 2 weeks of treatment, mice
Clinical Perspective
What Is New?
• This is the first report showing the mechanism involved in hypertension associated with DJ-1 depletion and identifies the novel role of uncoupling protein 2 in blood pressure regulation.
What Are the Clinical Implications?
• These data describe a new mechanism of the regulation of blood pressure and its possible implication in the pathogenesis of essential hypertension, and identify DJ-1 and uncoupling protein 2 as new possible targets for future new approaches to treatment of hypertension and renal diseases.
were housed in metabolic cages for 24-hour urine collection. At the end of the urine collection period, mice were anesthetized and BP was measured as described above.
Immunoblotting
Mouse kidney homogenates were subjected to immunoblotting, as previously reported. 7 The primary antibodies used were polyclonal rabbit anti-DJ- Table) , and primers for IL-6 (QT00098875), Ccl2 (QT00167832), Tnf-a (QT00104006), and NfjB (QT00134421) were purchased from Qiagen. GAPDH and beta-actin were used as housekeeping genes. RNA expression was detected with Quantitect SYBR green kit (Qiagen), using a CFX96 Touch reverse transcription polymerase chain reaction detection system (Bio-Rad).
Analytical Determinations
Levels of renin (Raybiotech, GA; catalog number ELM-Renin1-1), kidney injury marker-1 (KIM-1) (R&D Systems, Minneapolis, MN; catalog number MKM100), and nitrite/nitrate (R&D Systems, Minneapolis, MN, catalog number KGE001) were quantified in urine or serum using the protocols provided by the commercial kits. Malondialdehyde (Cell Biolabs, Inc, San Diego, CA; catalog number STA-332) production was quantified in kidney tissue homogenates using the protocols provided by the commercial kits. Urine sodium concentration was determined by EasyLyte electrolyte analyzer (Medexsupply, Passaic, NJ), and normalized by urine creatinine (Crystal Chem, IL; catalog number 80350) determined by a colorimetric method (Randox, Charles Town, WV). All assays were performed in duplicate.
Statistical Analyses
Data are presented as meanAESEM. Statistical analyses were performed using Sigma Plot 11.0 software (Systat Software, Inc., San Jose, CA). Comparisons between 2 groups used the Student t test. One-way ANOVA, followed by post hoc analysis using the Holm-Sidak multiple comparison test, was used to assess significant differences among 3 or more groups, and 2-way ANOVA with an interaction term included and a post hoc Bonferroni test was used when comparing more than 2 factors. P<0.05 was considered statistically significant.
Results

DJ-1 À/À Mice Present Oxidative StressDependent Hypertension
Our group has previously reported that renal DJ-1 depletion results in oxidative stress-dependent hypertension.
9,10 DJ-1 À/À mice presented a significant reduction of body weight ( Figure 1A ). Systolic and diastolic BP as well as renal expression of nitro-tyrosine were elevated, indicating the presence of oxidative stress in the kidney (Figures 1B and  1C) . However, serum creatinine was not affected by germline deletion of DJ-1 ( Figure 1D ). Renal expression of NADPH oxidase type 2 (Nox2) and type 4 (Nox4) as well as renal NADPH oxidase activity ( Figure 1E ) and extracellular hydrogen peroxide (H 2 O 2 ) concentration ( Figure 1F ) were also similar between DJ-1 À/À and wild-type mice. Additionally, sodium excretion corrected by urine creatinine ( Figure 1G ) was similar between the genotypes. Taken together, these results indicate that the exaggerated BP and renal oxidative stress associated with DJ-1 depletion are independent of NADPH oxidase activity and renal sodium transport. n=4) and renal malondialdehyde production (tempol: 160AE23% versus 109AE15% versus wild-type, n=4) in DJ-1
mice, but had no effect in their wild-type littermates (Figure 2A) . By contrast, treatment with tempol led to increased serum nitrite/nitrate levels in DJ-1 À/À mice (+72AE30%, n=4) ( Figure 2B ), suggesting that the nitric oxide system may be involved in the pathogenesis of hypertension in this animal model. Levels of serum renin were not changed by tempol; thus, hypertension in DJ-1 À/À mice is renin-angiotensin system-independent ( Figure 2C ). However, urinary excretion of the KIM-1 was increased in DJ-1 À/À mice (148AE22% of wildtype mice, n=4) and decreased by treatment with tempol (À58AE3%, n=4) ( Figure 2D ), indicating that the renal injury induced by the lack of DJ-1 is associated with increased ROS production. Importantly, whole body deletion of DJ-1 does not lead to renal morphology changes ( Figure 2E ). We speculate that the nitric oxide (NO) system is involved in the hypertension associated with germline deletion of DJ-1 ( Figure 2F ).
Deletion of DJ-1 Does Not Result in Exaggerated Renal Inflammation
To assess whether DJ-1 À/À mice deletion leads to changes in renal inflammation, we analyzed the mRNA expression of IL-6, Tnf-a, Mcp-1, and NfjB (Figure 3) , as well as renal infiltration of macrophages ( Figure 4 ) and T lymphocytes ( Figure 5 ) in kidneys of DJ-1 À/À and wild-type mice treated with vehicle or tempol. We found no differences between the groups, indicating that, despite the presence of oxidative stress and Figure 1 . Effect of DJ-1 deletion on BP, oxidative/nitrosative stress, Nox expression and activity, and sodium handling. A, DJ-1 À/À mice are smaller than wild-type littermates. B, Systolic BP was measured (Cardiomax II) from the aorta, via the femoral artery, under pentobarbital anesthesia. C, Renal homogenates were immunoblotted using antibodies against nitro-tyrosine. Data were normalized by GAPDH. Data are expressed as meanAESEM, n=5 to 8/group. *P<0.05 vs wild-type littermates, t test. D, Serum creatinine concentration was determined by Randox colorimetric method. Data are expressed as meanAESEM, n=5 to 8/group; there are no significant differences among the groups. E, Renal homogenates were immunoblotted using antibodies against Nox2 and Nox4. Data were normalized by GAPDH. NADPH oxidase activity (light units per milligram of protein) was determined by lucigenin (5 lmol/L) assay. F, H 2 O 2 expression was determined by Amplex red in renal homogenates. Data are expressed as meanAESEM, n=4/group. G, Urine sodium excretion was determined by EasyLyte electrolyte analyzer, and normalized by creatinine. Data are expressed as meanAESEM, n=4/group. There are no significant differences among the groups. BP indicates blood pressure; Nox, NADPH oxidase. A, Systolic BP in DJ-1 À/À mice. Systolic BP was measured (Cardiomax II) from the aorta, via the femoral artery, under pentobarbital anesthesia in DJ-1 À/À mice and wild-type littermates (n=4/group). The mice were treated with tempol (6 mmol/L) or vehicle added to the drinking water for 2 weeks. pre=BP values before treatment; post=BP values after treatment. MDA concentration (corrected for protein concentration) in kidney homogenates was measured using a commercial kit (Cell Biolabs, Inc). Data are expressed as meanAESEM, n=4/group.*P<0.05 vs others groups, 1-way ANOVA. B through D, Serum nitrite/nitrate and renin, and urinary KIM-1 were quantified by ELISA commercial kits. Data are expressed as meanAESEM, n=4/group.*P<0.05 vs others groups, 1-way ANOVA. E, Kidney sections of wild-type and DJ-1 À/À mice treated with tempol were stained with hematoxylin and eosin. No differences were found between the 2 mouse strains. F, Proposed mechanism of action of tempol to prevent DJ-1 À/À deletion-mediated hypertension: tempol increases the NO bioavailability by preventing its conversion to peroxynitrite and nitro-tyrosine and resulting in increased vasodilatation and nitrite/nitrate serum concentration and decreased BP. BP indicates blood pressure; KIM-1, kidney injury molecule-1; MDA, malondialdehyde; NO, nitric oxide; ONOO, Nitro-tyrosine; SOD, superoxide.
hypertension, DJ-1 À/À mice do not present exaggerated renal inflammation.
Germline DJ-1 Deletion Increases Heat Shock Protein 60 and UCP2 in the Kidney
Because mitochondria are well-known sources of superoxide and other ROS, 11 we examined the renal expression of different markers of mitochondrial stress in the experimental animals. There were no differences between the groups in the mRNA expression of markers of mitophagy, mitochondrial fusion, and fission or biogenesis between DJ-1 À/À mice and wild-type ( Figure 6A ). mRNA expression of mitochondrial heat shock protein 60 (mtHsp60) was elevated in kidneys of DJ-1 À/À mice (2.9AE0.1-fold, n=4), while expression of mtHsp40 was not different between the groups ( Figure 6B ). These results suggest that the lack of DJ-1 expression resulted in mitochondrial stress, likely caused by oxidative redox imbalance. Interestingly, treatment with tempol led to a significant difference in the expression of mtHsp40 between the genotypes (wildtype+tempol versus DJ1 À/À +tempol: 0.6AE0.2 versus 1.2AE0.1, n=4), but failed to inhibit the renal mRNA expression of Hsp60 in DJ-1 À/À mice. By contrast, the renal expression of Ucp2, which decreases the production of superoxide in the mitochondria 11 and was significantly elevated in DJ-1 À/À mice (4.1AE1.1-fold of wild-type, n=4), was normalized by treatment with tempol ( Figure 6B ). Thus, it is possible that compensatory renal overexpression of Ucp2 in these animals in response to the lack of DJ-1 could provide an additional protection on mitochondrial function and prevents the development of renal damage. 11, 12, 15, 32 Interestingly, and contrary to our expectations, the protein expression of mtHsp60 in the kidney was not different among the groups, possibly highlighting a time lag in the translation of mRNA to protein in the timeline of our experiments ( Figure 6C ; P>0.05).
Endoplasmic reticulum stress has been closely associated with oxidative stress and mitochondrial stress, 33 ,34 renal diseases, and hypertension. 35, 36 To elucidate the molecular mechanisms involved in the development of hypertension in the DJ-1 À/À mouse, we measured the mRNA expression of markers of endoplasmic reticulum stress and mitochondrial stress in kidneys of our experimental animals. Renal expression of the endoplasmic reticulum stress markers GRP94, ATF-4, ATF-6, spliced XBP-1, CHOP, and caspase 12 was not different between wild-type and DJ-1 À/À mice. Furthermore, treatment with tempol did not affect their expression ( Figure 7 ).
Renal-Selective Silencing of Ucp2 Normalizes BP in DJ-1 À/À Mice
To better understand the role of Ucp2 in the control of BP and, possibly, kidney injury, Ucp2 expression was silenced specifically in the kidney of DJ-1 À/À mice and wild-type littermates, via renal subcapsular infusion of Ucp2 siRNA. 9,10 The efficiency of Ucp2 silencing by Ucp2 siRNA infusion into the kidney was determined by quantitative polymerase chain reaction, and we determined that it was similar in both genotypes (nonspecific siRNA versus Ucp2: wild-type À0.63AE0.07-fold and DJ1 À/À À0.60AE0.06-fold) ( Figure 8A ). decreased production of NO is involved in the development of elevated BP in DJ-1 À/À mice ( Figure 8C ). KIM-1 levels in the kidney were not altered by renal Ucp2 siRNA infusion and remained elevated in the DJ-1 À/À mice compared with wildtype littermates ( Figure 8D) . Similarly, the mRNA expression levels of the mitochondrial stress markers mtHsp40 and mtHsp60 in the kidney were not affected by the kidney-specific silencing of Ucp2 (mtHsp40, wild-type nonsilencing siRNA 
Discussion
We recently reported that disruption of DJ-1 in mice causes oxidative stress-dependent hypertension. 5, 10 We now report that DJ-1 deletion leads to exaggerated reactive nitrogen species production, lipid peroxidation, and renal cortical injury, and results in elevated expression of Ucp2 Figure 6 . Effect of DJ-1 deletion on mitochondrial oxidative stress. A and B, mRNA expression the markers of mitophagy; Bcl2 interacting protein 3 (Bnip3), Bcl2 interacting protein 3 like (Bnip3L), PTEN-induced putative kinase 1 (Pink1), the markers of mitochondrial fusion and fission; fission mitochondrial 1 (Fis1), mitofusin 1 (Mfn 1), mitofusin 2 (Mfn 2), mitochondrial biogenesis; peroxisome proliferator-activated receptor c coactivator-related 1 (Pprc1), peroxisome proliferator-activated receptor c coactivator 1 a (Pgc1-a), and nuclear respiratory factor 1 (Nrf-1) and mitochondrial heat shock proteins 40 and 60 (mtHsp40 and mtHsp60) as well as uncoupling proteins 2 (Ucp2) were determined in kidneys of DJ-1 À/À mice and wild-type littermates by quantitative real-time polymerase chain reaction and normalized by GAPDH. C, mtHsp60 protein expression was assessed by Western blot and normalized by GAPDH protein expression. Data are expressed as meanAESEM, n=4/group. *P<0.05 vs wildtype mice; # P<0.05 vs DJ1 À/À mice treated with vehicle, 2-way ANOVA.
in the kidney. We further show that specific silencing of Ucp2 in the kidney normalizes BP in this experimental model. To our knowledge, this is the first report showing the ability of UCP2 to regulate BP and decrease NO activity.
DJ-1 Depletion Results in Increased Reactive Nitrogen Species and Increased Renal Expression of Ucp2, Which Is Normalized by Treatment With the Antioxidant Tempol
DJ-1 is a peroxiredoxin protein that exerts a protective role against oxidative stress. 37 Our group previously showed that DJ-1 is involved in the antioxidant activity mediated by dopamine 2 receptors, which is mainly associated with their ability to inhibit NADPH oxidase activity. 8, 9 Our present studies demonstrate that the oxidative stress-dependent hypertension observed in DJ-1 À/À mice is independent of changes in NADPH oxidase activity and regulation of renal sodium excretion. We also demonstrate that DJ1 À/À mice have increased renal levels of nitro-tyrosine, a marker of peroxynitrite production and thus, nitrogen species production. 38 Moreover, nitric oxide production is decreased by germline deletion of DJ-1, as indicated by the decreased serum and renal nitrite/nitrate ratio in DJ-1 À/À mice.
Interestingly, treatment with the antioxidant tempol increases the nitrite/nitrate ratio in the kidney in DJ-1
mice, suggesting that the hypertension in DJ-1 À/À mice is caused by NO dysregulation, probably caused by deficient function of the nitric oxidase system and independently of changes in the renal angiotensin system or NADPH oxidase activity. Treatment with tempol also normalizes the excretion of the proximal tubular damage marker KIM-1, indicating that the kidney damage induced by loss of DJ-1 is ROS dependent.
Lack of DJ-1 Function Results in Increased mtHsp60 and Ucp2 Expression in the Kidney
Because DJ-1 has an important role in protecting mitochondrial function, 39, 40 and mitochondrial dysfunction has been repeatedly associated with hypertension, 41 the renal mitochondrial status of DJ1 À/À mice was assessed in animals treated with vehicle or tempol. Significantly elevated expression of mitochondrial heat shock protein 60 (mtHsp60) and Ucp2 was observed in kidneys from DJ-1 À/À mice treated with vehicle. Elevated levels of unfolded proteins in cellular compartments activate chaperone gene transcription and facilitate the further folding of misfolded proteins into their active conformations. 42 Mitochondria contain several members of the heat-shock protein (mtHsp) family that assist with proteostasis within this organelle and, therefore, help in maintaining mitochondrial function. In particular, mtHsp60 is expressed in the mitochondrial matrix, and its expression is upregulated in response to mitochondrial disorders, 43, 44 and thus, it is considered a marker of mitochondrial stress. Increased expression of mtHsp60 has been associated with cardiovascular diseases, 44, 45 diabetes mellitus, 46, 47 Alzheimer's disease, 48, 49 and cancer. 49 In our studies, treatment with tempol did not decrease the expression of mtHsp60 in the kidneys of DJ-1 À/À mice, possibly caused by tempol not specifically targeting the mitochondria. Although we also measured mtHsp60 protein expression, differences were not found between groups. ATP-and ubiquitin-independent 20S proteasome have been reported to play a key role in the selective removal of oxidized proteins 50, 51 ; therefore we speculate that the overoxidation of mtHsp60 in our experimental animals, likely due the increased the ROS expression in the mitochondria, induces its degradation. The increased degradation of overoxidized mtHsp60 may, in turn, lead to increased mRNA expression caused by a feedback regulation mechanism. We will further investigate this avenue in future studies.
On the other hand, treatment with tempol led to a difference in expression of mtHsp40 between the genotypes, with the DJ-1 À/À mice showing significantly greater expression than the wild-type mice. mtHsp40 has an important role in the maintenance of mitochondrial proteostasis, mainly by aiding with protein refolding. 52 Elwi et al 53 demonstrated an association between dysregulation of mtHsp40 and mitochondrial fragmentation, and suggested a critical role of this chaperone protein in the modulation of mitochondrial morphology. 54 Tempol has been reported to attenuate ROSmediated tissue damage, 55 but is not able to protect the mitochondria from an excessive ROS production, and this may induce oxidative stress. Our results demonstrate that treatment with tempol unmasks mitochondrial oxidative stress associated with germline deletion of DJ-1 À/À , as highlighted by the elevated expression of mtHsp40 and mtHsp60 in the kidney. UCPs protect against oxidative stress and attenuate both mitochondrial ROS production 56 and apoptosis in renal ischemia-reperfusion injury. 57 There are 5 subtypes of UCPs:
UCP1 to UCP5. 58 UCP2 in particular is highly expressed in the kidney. 59 UCP2 has been reported to regulate mitochondrial dynamics (mitochondrial fission and fusion), 60 as well as to Figure 7 . Expression of markers of endoplasmic reticulum stress in the cortex is similar among the genotypes and treatments. mRNA expressions of GRP94 (a chaperone involved in the processing and transport of secreted proteins), ATF-4, ATF-6, sXBP-1, CHOP, and caspase 12 in renal cortex of DJ-1 À/À mice and wild-type littermates were quantified by quantitative real-time polymerase chain reaction and normalized to GAPDH. n=4/group. No differences were found between the 2 mouse strains. ATF-4 indicates activating transcription factor 4; ATF-6, activating transcription factor 6; CHOP C/EBP-homologous protein; GRP94, glucose-regulated protein; sXBP-1, spliced X box-binding protein 1. protect against mitochondrial dysfunction by reducing the release of anion superoxide in the electron transport chain. 61 Moreover, it has been speculated that the antioxidant properties of UCP2 may be caused by its ability to increase the mitochondrial glutathione levels. 62 However, the beneficial effects of UCP2 against oxidative stress remain unclear.
63
UCP2 deficiency in mice is protective against cerebral ischemia following middle cerebral artery occlusion, 62 whereas UCP2 overexpression in the brain prevents stroke and decreases neuronal death. 64 The role of UCP2 in kidney damage is controversial in the literature. While a role for UCP2 in promoting kidney fibrosis has been described in a model of chronic kidney injury, 65 recent reports have unveiled a protective role of UCP2 against the development of kidney ischemia/reperfusion injury through inhibition of tubular apoptosis and induction of autophagy. 57 Our results indicate that a lack of DJ-1 is associated with upregulation of Ucp2 in the kidney, and that treatment with tempol normalizes these levels in DJ-1 À/À mice. Ucp2 expression is activated by ROS 66 ; thus our results suggest that Ucp2 could have been induced by the increased production of ROS in our hypertensive mouse model. The elevated expression of mtHsp40 and mtHsp60 that accompany the upregulation of Ucp2 in the DJ-1 À/À model further supports this conclusion.
Ucp2 Overexpression Increases BP in DJ-1
Mice
Our results suggest that Ucp2 is involved in the elevated BP associated with DJ-1 depletion. It has been reported that longterm Ucp2 overexpression could induce deleterious effects, instead of its usual beneficial effects. Decreased UCP2 expression would impair its antioxidant properties. 15, 17, 67 Although the increased renal expression of Ucp2 in DJ-1
mice may act as a compensatory mechanism to preserve mitochondrial function in this model, an excessive elevation of Ucp2 expression in the kidney may also lead to decreased nitric oxide production and elevated BP. Renal Ucp2 expression is increased 5-fold in DJ-1 À/À mice, and ROS is known to elevate Ucp2 expression; thus, the exaggerated expression of renal Ucp2 in our animals could be ROS mediated. This notion is supported by the decreased Ucp2 expression and normalized BP values in DJ-1 À/À mice after treatment with tempol.
This may indicate that excessive and chronic overexpression of Ucp2 could have deleterious consequences on BP regulation in DJ-1 À/À mice, but this effect would not be observed in normal conditions and moderate expression of Ucp2. 70 It has also been reported that increased cytoplasmic Ca 2+ leads to increase NO production and improved endothelial function. 71, 72 In our experience, silencing Ucp2 expression in kidneys of DJ-1 À/À mice normalized the nitrite/nitrate concentration in serum, indicating that the nitric oxide system is critically involved in the hypertension in DJ-1 À/À mice. We speculate that exaggerated Ucp2 expression in the kidney could lead to increased Ca 2+ uptake in the mitochondria, decreasing NO production and, thus, increasing BP ( Figure 9 ). Further experiments are needed to test this working hypothesis.
Perspectives
Our data indicate that an exaggerated and prolonged increase in renal Ucp2 levels leads to elevated BP in DJ1 À/À mice, caused by decreased nitric oxide production, suggesting that excessive Ucp2 expression may have deleterious consequences on BP regulation. Further studies are needed to understand the complex interaction between UCP2 and BP regulation and to establish whether or not modulation of renal DJ-1 and UCP2 function can be a new therapeutic approach in renal diseases and hypertension.
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